Phibro Animal Health (PAHC) Competitors

Phibro Animal Health (NASDAQ:PAHC) and PTC Therapeutics (NASDAQ:PTCT) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, media sentiment, valuation, dividends, earnings and profitability.

Which has preferable earnings and valuation, PAHC or PTCT?

Phibro Animal Health has higher earnings, but lower revenue than PTC Therapeutics. PTC Therapeutics is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phibro Animal Health	$1.19B	1.04	$2.42M	$0.78	39.32
PTC Therapeutics	$1.76B	2.20	-$363.30M	$6.97	7.00

Which has more risk & volatility, PAHC or PTCT?

Phibro Animal Health has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. Comparatively, PTC Therapeutics has a beta of 0.54, meaning that its stock price is 46% less volatile than the S&P 500.

Is PAHC or PTCT more profitable?

PTC Therapeutics has a net margin of 35.65% compared to Phibro Animal Health's net margin of 2.68%. Phibro Animal Health's return on equity of 30.51% beat PTC Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phibro Animal Health	2.68%	30.51%	6.89%
PTC Therapeutics	35.65%	-106.31%	30.61%

Do analysts recommend PAHC or PTCT?

Phibro Animal Health presently has a consensus price target of $24.40, suggesting a potential downside of 20.44%. PTC Therapeutics has a consensus price target of $70.15, suggesting a potential upside of 43.70%. Given PTC Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe PTC Therapeutics is more favorable than Phibro Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phibro Animal Health	2 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.83
PTC Therapeutics	1 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.63

Does the media favor PAHC or PTCT?

In the previous week, PTC Therapeutics had 7 more articles in the media than Phibro Animal Health. MarketBeat recorded 15 mentions for PTC Therapeutics and 8 mentions for Phibro Animal Health. Phibro Animal Health's average media sentiment score of 0.99 beat PTC Therapeutics' score of 0.66 indicating that Phibro Animal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Phibro Animal Health	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PTC Therapeutics	5 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders have more ownership in PAHC or PTCT?

99.3% of Phibro Animal Health shares are held by institutional investors. 50.1% of Phibro Animal Health shares are held by insiders. Comparatively, 5.5% of PTC Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

PTC Therapeutics beats Phibro Animal Health on 10 of the 17 factors compared between the two stocks.